Go Pro
OTCMKTS:MEDIF

MediPharm Labs (MEDIF) Stock Price, News & Analysis

MediPharm Labs logo
$0.06 0.00 (0.00%)
As of 08/25/2026 03:44 PM Eastern

About MediPharm Labs Stock (OTCMKTS:MEDIF)

Advanced

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.05
$0.06
52-Week Range
$0.04
$0.08
Volume
60,862 shs
Average Volume
81,835 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products. MediPharm Labs also provides custom formulation and white-label manufacturing services to licensed producers and pharmaceutical partners, delivering turnkey solutions from initial concept through commercial production.

MediPharm Labs serves domestic clients across Canada’s provincial distribution networks and is advancing export opportunities in Europe and Latin America under evolving regulatory frameworks. Its operations emphasize consistent quality, rigorous testing, and strict adherence to international standards, positioning the company as a preferred partner for institutional and research-focused customers.

Founded in 2015 by Kully Saluja, who serves as President and CEO, MediPharm Labs has expanded its capacity through strategic investments in automation and analytics. The leadership team combines expertise in pharmaceutical manufacturing, regulatory compliance and cannabis science, guiding the company’s growth as it scales production and explores new markets.

AI Generated. May Contain Errors.

Receive MEDIF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPharm Labs and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MEDIF Stock News Headlines

It’s not about Greenland
The petrodollar arrangement that anchored the US dollar for 50 years quietly expired in June 2024. Since then, China has cut its Treasury holdings by 45% from their peak, and BRICS nations offloaded $47 billion of American debt in a single month. The Trump administration has responded with a $12 billion critical minerals stockpile called Project Vault, equity stakes in miners like MP Materials and Lithium Americas, and a push to secure resources from Greenland to Ukraine. Porter Stansberry lays out the full story in a new documentary, including five companies positioned at the chokepoints of what he calls Trump's New Dollar.tc pixel
MediPharm Labs Corp MEDIF
See More Headlines

MEDIF Stock Analysis - Frequently Asked Questions

MediPharm Labs' stock was trading at $0.0498 at the beginning of 2026. Since then, MEDIF shares have increased by 14.1% and is now trading at $0.0568.

Shares of MEDIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:MEDIF
CIK
N/A
Fax
N/A
Employees
166
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:MEDIF) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners